Long-Term Monitoring and Patient Engagement Managing slowed progress during GLP-1 therapy requires continuous communication and realistic goal setting
At The Institute for Weight Management, we use GLP-1 injections to help individuals lose weight in a medically supervised manner
Imagine someone who starts semaglutide at 32 and stays on it until 50
Clinical trials and FDA labeling show eructation or burping occurs in approximately 3% of people taking Ozempic injection, up to 2% in people taking Rybelsus (rebranded to Ozempic pill), about 7% of those on Wegovy, and 25% with Mounjaro and Zepbound
GLP-1 is a naturally occurring hormone that is released by the cells in the small intestine when food, particularly carbohydrates, hits the stomach, explains Thomas Wadden, professor of psychology at the University of Pennsylvania Perelman School of Medicine